The U.S. House of Representatives has approved a federal spending bill that could significantly change how military veterans access medical cannabis in states where marijuana treatment is legal. The legislation, known as the Military Construction, Veterans Affairs, and Related Agencies Appropriations Act for Fiscal Year 2027, includes language that would allow physicians associated with the Department of Veterans Affairs to recommend medical cannabis to veterans under state-approved programs. The House passed the broader appropriations measure on May 15, 2026, by a vote of 400-15, sending the issue to the Senate as part of the next stage of the federal budget process.
For veterans who rely primarily on VA health care, the provision addresses a long-running contradiction in federal policy. In many states, medical marijuana is legally available to qualifying patients, including those dealing with chronic pain, post-traumatic stress, anxiety, sleep disorders, and other service-related conditions. Yet VA doctors have remained restricted from completing the paperwork or issuing the recommendations needed for veterans to participate in those state programs. That has forced many veterans to seek outside physicians, often paying out of pocket, even though their regular medical care is handled through the VA system.
A Bipartisan Cannabis Provision Inside a Veterans Funding Bill
The medical cannabis language was introduced by Congressional Cannabis Caucus co-chairs Rep. Brian Mast of Florida, Rep. Dina Titus of Nevada, and Rep. David Joyce of Ohio. Their amendment targets a specific VA policy barrier rather than attempting to legalize cannabis nationwide. According to reporting on the amendment, the language would prevent the VA from using funds to enforce parts of Veterans Health Directive 1315 that prohibit VA providers from recommending, referring, completing forms, or registering veterans for participation in state medical marijuana programs.
That distinction matters because the proposal does not create a federal cannabis program, require the VA to distribute marijuana, or override state law. Instead, it would allow VA clinicians to act in accordance with medical cannabis laws already in place in a veteran’s state. If enacted, veterans in legal medical cannabis states could potentially discuss cannabis use more openly with their VA physicians and receive the necessary documentation through the same health care system they already use.
The House vote also reflects the increasingly bipartisan nature of veterans’ cannabis policy. Cannabis reform remains politically divided in many areas, but veterans’ access has become one of the more durable points of agreement. Supporters argue that veterans should not be punished for receiving care through a federal health system, especially when civilians in the same state can obtain medical cannabis recommendations from private doctors.
Why the Change Matters for Veterans
The current system creates a practical and financial burden for veterans. VA doctors may discuss cannabis use with patients, but they cannot help them complete the state medical marijuana process. For veterans with limited income, mobility challenges, or complex health conditions, finding and paying for a separate private physician can be a major obstacle. NORML noted that this can force veterans into costly private consultations simply to access a legal state medical cannabis program.
The issue is especially important because cannabis use is already present among veterans. NORML reports that approximately one in ten military veterans say they use cannabis, and nearly half of those users report therapeutic reasons, including managing chronic pain and symptoms associated with post-traumatic stress. Supporters of the amendment argue that allowing VA providers to participate would bring that use into the open, improving patient-provider communication and reducing reliance on unregulated sources.
From a health care perspective, the change could also give VA doctors a more complete picture of a veteran’s treatment plan. When patients feel unable to discuss cannabis honestly with their physicians, doctors may not know about possible interactions, patterns of use, side effects, or whether cannabis is replacing other medications. Allowing VA doctors to issue recommendations in legal states could make medical cannabis part of a more transparent clinical conversation rather than something veterans pursue outside the system.
Medical Cannabis, Chronic Pain, and PTSD
The push for veterans’ medical cannabis access is closely tied to the ongoing search for alternatives in pain management and mental health care. Many veterans live with chronic pain, traumatic injuries, sleep disruption, anxiety, depression, or PTSD symptoms related to military service. While cannabis is not a cure-all and research remains ongoing, many veterans report using it as part of their symptom-management strategy. Supporters argue that federal policy should allow VA clinicians to help veterans make informed decisions within legal state frameworks rather than pushing them toward disconnected private providers.
This issue also intersects with broader concerns about opioids and long-term prescription drug use. Veterans’ groups and cannabis reform advocates have long argued that medical marijuana may offer some patients an alternative or adjunct to more traditional medications. The House provision does not settle the scientific debate, but it would remove a bureaucratic barrier that prevents VA doctors from participating in state medical cannabis systems where cannabis is already legal.
At the same time, the measure does not eliminate the need for careful medical oversight. Cannabis products vary widely in potency, cannabinoid profile, route of administration, and quality control. That is one reason advocates prefer access through regulated state programs rather than informal or illicit markets. NORML argues that allowing VA physicians to recommend cannabis in accordance with state law would help veterans access regulated, lab-tested products through licensed providers.
The Bill Still Faces the Senate
Although the House vote is a major step, the cannabis language is not yet law. The FY2027 appropriations bill must still move through the Senate, where lawmakers can keep, modify, or remove the provision. Military Times reported that the Senate still has to craft its own version of the MilConVA bill, with the Senate process expected to continue through the summer.
That uncertainty is important because similar veterans’ medical cannabis provisions have advanced before without making it into final law. NORML reported that both chambers included comparable language in military funding bills last year, but the provision was left out of the consolidated final package. Marijuana Moment also noted that similar proposals have passed in previous years but have not been enacted.
The path forward will likely depend on whether the Senate includes matching or compatible language and whether the provision survives final negotiations between the House and Senate. Appropriations riders can be powerful policy tools, but they are also vulnerable during closed-door negotiations, especially when broader spending fights take priority.
Part of a Larger Veterans Health Care Package
The cannabis provision is only one piece of a much larger spending bill. According to the House Appropriations Committee, the FY2027 Military Construction and Veterans Affairs bill includes a $157 billion discretionary allocation, nearly $4 billion above the FY2026 enacted level, along with $323.9 billion for mandatory programs, bringing the total to about $469.49 billion for the fiscal year. The bill funds veterans’ health care, benefits, mental health programs, VA facility improvements, military construction, housing, childcare, and other military family priorities.
Military Times reported the bill includes nearly $450 billion for the VA, a roughly 3 percent increase from fiscal 2026, though below the administration’s requested level. The broader measure also includes funding for military construction projects and veterans-related agencies such as Arlington National Cemetery and the American Battle Monuments Commission.
Because the medical cannabis language is embedded in a must-pass funding category rather than moving as a standalone marijuana reform bill, supporters may see a better chance of progress. Veterans’ health care funding is politically difficult to oppose, and the House’s overwhelming vote suggests broad support for the underlying legislation. Still, the final outcome will depend on the Senate and the budget reconciliation process.
A Narrow Reform With Broader Symbolic Weight
The House-approved provision is narrow, but its symbolic meaning is larger. For decades, federal cannabis prohibition has created conflicts between state medical marijuana laws and federal health systems. Veterans have been caught in the middle: eligible under state law, but blocked from receiving the same kind of recommendation through the VA that other patients can receive from private doctors.
If the provision becomes law, it would not legalize cannabis federally, nor would it require every VA doctor to recommend marijuana. But it would represent a meaningful shift in federal veterans policy by acknowledging that veterans in legal states should be able to seek medical cannabis guidance through their own health care providers. For patients who already use VA services, that could mean less cost, less confusion, and more honest conversations about cannabis as part of their broader care.
For now, the measure remains a House-approved proposal awaiting Senate action. But its inclusion in the FY2027 veterans funding bill shows that medical cannabis access for veterans has moved from the margins of cannabis reform into the center of federal health care policy debates. Whether it survives the next stage will determine whether veterans in legal states finally gain the ability to receive cannabis recommendations through the VA system they earned through service.
